Literature DB >> 14505809

Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol.

Jun Sik Hong1, Hyun Hee Ko, Eun Sook Han, Chung Soo Lee.   

Abstract

The mitochondrial permeability transition is recognized to be involved in toxic and oxidative forms of cell injury. In the present study, we investigated the effect of ambroxol against the cytotoxicity of bleomycin (BLM) by looking at the effect on the mitochondrial membrane permeability in alveolar macrophages and lung epithelial cells. Alveolar macrophages or lung epithelial cells exposed to BLM revealed the loss of cell viability and increase in caspase-3 activity. Ambroxol (10-100 microM) reduced the 75 mU/mL BLM-induced cell death and activation of caspase-3 in macrophages or epithelial cells. It reduced the condensation and fragmentation of nuclei caused by BLM in macrophages. Ambroxol alone did not significantly cause cell death. Treatment of alveolar macrophages with BLM resulted in the decrease in transmembrane potential in mitochondria, cytosolic accumulation of cytochrome c, increase in formation of reactive oxygen species (ROS) and depletion of GSH. Ambroxol (10-100 microM) inhibited the increase in mitochondrial membrane permeability, ROS formation and decrease in GSH contents due to BLM in macrophages. Ambroxol exerted a scavenging effect on hydroxyl radicals and nitric oxide and reduced the iron-mediated formation of malondialdehyde and carbonyls in liver mitochondria. It prevented cell death due to SIN-1 in lung epithelial cells. The results demonstrate that ambroxol attenuates the BLM-induced viability loss in alveolar macrophages or lung epithelial cells. This effect may be due to inhibition of mitochondrial damage and due to the scavenging action on free radicals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505809     DOI: 10.1016/s0006-2952(03)00448-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Haşim Boyaci; Hale Maral; Gupse Turan; Ilknur Başyiğit; Meltem O Dillioğlugil; Füsun Yildiz; Melih Tugay; Ayşe Pala; Cengiz Erçin
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Authors:  Simona Inghilleri; Patrizia Morbini; Tiberio Oggionni; Sergio Barni; Carla Fenoglio
Journal:  Histochem Cell Biol       Date:  2005-11-24       Impact factor: 4.304

3.  Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells.

Authors:  Sun Joo Lee; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

4.  Antitumor Effects of Camptothecin Combined with Conventional Anticancer Drugs on the Cervical and Uterine Squamous Cell Carcinoma Cell Line SiHa.

Authors:  Sang Won Ha; Yun Jeong Kim; Wonyong Kim; Chung Soo Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

5.  Effect of early treatment with transcutaneous electrical diaphragmatic stimulation (TEDS) on pulmonary inflammation induced by bleomycin.

Authors:  Laisa A Santos; Carlos A Silva; Maria L O Polacow
Journal:  Braz J Phys Ther       Date:  2013-11-14       Impact factor: 3.377

6.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

7.  Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway.

Authors:  Yan-Lu Liu; Bao-Yi Chen; Juan Nie; Guang-Hui Zhao; Jian-Yi Zhuo; Jie Yuan; Yu-Cui Li; Ling-Li Wang; Zhi-Wei Chen
Journal:  Exp Ther Med       Date:  2020-09-04       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.